Replies to post #49 on Onyx Pharmaceuticals Inc (ONXX)

[surf1944]

Onyx Pharmaceuticals' CFO say company attractive target, Bloomberg reports
Theflyonthewall.comTheflyonthewall.com –

Matt Fust, the CFO of Onyx Pharmaceuticals (ONXX), which developed the kidney cancer drug Nexavar, said the company is an attractive target for acquirers because it may receive regulatory approvals for several new treatments during the next year, reports Bloomberg.